Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

Summary

This is an Expanded Access program (EAP), sponsored by WideTrial for the treatment of critical limb ischemia (CLI). Widetrial, an Expanded Access specialist, has arranged to supply participating sites with PLX-PAD for CLI patients who cannot participate in the ongoing research trial and who seek exploratory treatment options. This program includes FDA-authorized cost recovery, meaning payment is required to cover a portion of the costs of delivering product and complying with regulatory obligations.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications